The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality

Alimentary Pharmacology and Therapeutics

Volumn 40, Issue 6, 2014, Pages 705-715

  Taylor, N J ^a   Manakkat Vijay, G K ^a   Abeles, R D ^a   Auzinger, G ^a   Bernal, W ^a   Ma, Y ^a   Wendon, J A ^a   Shawcross, D L ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERICIDAL ACTIVITY; BLOOD CHEMISTRY; CELL PHAGOCYTOSIS; CIRCULATING NEUTROPHIL DYSFUNCTION; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; FLUOROCHROME STAINING; GRANULOCYTE FUNCTION; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGY; MORTALITY; NEUTROPHIL; ORGAN DYSFUNCTION SCORE; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RESPIRATORY BURST; SENSITIVITY AND SPECIFICITY; SURVIVAL PREDICTION;

ADULT; CYTOKINES; ESCHERICHIA COLI; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NEUTROPHILS; PHAGOCYTOSIS; PROSPECTIVE STUDIES; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST;

EID: 84906220081     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12886     Document Type: Article

References (26)

1. Fernandez J, Navasa M, Gomez J, et al,. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35: 140-8.
2. British Association for the Study of the Liver and British Society of Gastroenterology (Liver Section). A Time to Act: Improving Liver Health and Outcomes in Liver Disease. London: National Plan for Liver Services U.K., 2009.
3. Wasmuth H, Kunz D, Yagmur E, et al,. Patients with acute on chronic liver failure display 'sepsis-like' immune paralysis. J Hepatol 2005; 42: 195-201.
4. Shawcross D, Wright G, Stadlbauer V, et al,. Ammonia impairs neutrophil phagocytic function in liver disease. Hepatology 2008; 48: 1202-12.
5. Rajkovic IA, Williams R,. Mechanisms of abnormalities in host defences against bacterial infection in liver disease. Clin Sci (Lond) 1985; 68: 247-53.
6. Sabroe I, Prince LR, Jones EC, et al,. Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span. J Immunol 2003; 170: 5268-75.
7. Condliffe AM, Kitchen E, Chilvers ER,. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 1998; 94: 461-71.
8. Colotta F, Re F, Polentaruuti N, Sozzani S, Mantovani A,. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 1992; 80: 2012-20.
9. Hayashi F, Means TK, Luster AD,. Toll-like receptors stimulate human neutrophil function. Blood 2003; 102: 2660-9.
10. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF,. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006; 368: 157-69.
11. Awad AS, Rouse M, Huang L, et al,. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 2009; 75: 689-98.
12. Nuytinck HK, Offermans XJ, Kubat K, Goris RJ,. Whole body inflammation in trauma patients; an autopsy study. Prog Clin Biol Res 1987; 236A: 55-61.
13. Smith JA,. Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994; 56: 672-86.
14. Moreau R, Jalan R, Gines P, et al,. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-37; 1437.
15. Conn H, Lieberthal M,. The hepatic coma syndromes and lactulose. Baltimore: Williams and Wilkins, 1979.
16. Taylor NJ, Nishtala A, Manakkat Vijay GK, et al,. Circulating neutrophil dysfunction in acute liver failure. Hepatology 2013; 57: 1142-52.
17. Rajkovic IA, Williams R,. Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis. Hepatology 1986; 6: 252-62.
18. Tritto G, Bechlis Z, Stadlbauer V, et al,. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol 2011; 55: 574-81.
19. Kirsch R, Woodburne VE, Shephard EG, Kirsch RE,. Patients with stable uncomplicated cirrhosis have normal neutrophil function. J Gastroenterol Hepatol 2000; 15: 1298-306.
20. Neugebauer H, Hartmann P, Krenn S, et al,. Bacterial translocation increases phagocytic activity of polymorphonuclear leucocytes in portal hypertension: priming independent of liver cirrhosis. Liver Int 2008; 28: 1149-57.
21. Levy R, Schlaeffer F, Keynan A, Nagauker O, Yaari A, Sikuler E,. Increased neutrophil function induced by bile duct ligation in a rat model. Hepatology 1993; 17: 908-14.
22. Bode C, Kugler V, Bode J,. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987; 4: 8-14.
23. Serste T, Melot C, Francoz C, et al,. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology 2010; 52: 1017-22.
24. Bellot P, Garcia-Pagan JC, Frances R, et al,. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology 2010; 52: 2044-52.
25. Lee W, Harrison R, Grinstein S,. Phagocytosis by neutrophils. Microbes Infect 2003; 5: 1299-306.
26. Mookerjee R, Stadlbauer V, Lidder S, et al,. Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts outcome. Hepatology 2007; 46: 831-40.